Clinical Trials Search | Clareo Health | Clareo Health

About Pricing FAQs Blog

Loading clinical trials...

Clareo Health Find Clinical Trials →

© 2026 Clareo Health. All rights reserved.

Filters

Sort by

Status

Recruiting(Enrolling)

Not yet recruiting

Active, not recruiting

Enrolling by invitation(Enrolling)

Completed

Terminated

Phase

Early Phase 1

Phase 1

Phase 1/Phase 2

Phase 2

Phase 2/Phase 3

Phase 3

Phase 4

Not Applicable

Eligibility

Accepts healthy volunteers

Showing 1-1 of 1 trials

RECRUITINGPHASE1/PHASE2

Phase I/II Study of Engineered T Cell Receptor-Modified NK Cells Targeting PRAME in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Myeloid Malignancies

NCT06383572

To find a recommended dose of PRAME-TCR-NK cells that can be given to patients with AML or MDS.

Lymphodepleting ChemotherapyMyeloid Malignancies

M.D. Anderson Cancer Center44 participantsStarted Jun 2024

Houston, Texas, United States

Data from ClinicalTrials.govTerms